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closely related to E. coli, as was pre-
viously observed in Tanzania (9). This
finding is also the first report of CTX-
M-3 in sub-Saharan Africa.
Multidrug resistance profiles
involving non–β-lactam antimicrobial
drugs coselected these ESBL-produc-
ing isolates. We suggest that the mis-
use of antimicrobial drugs in the
Central African Republic and the
migratory flux of regional populations
could result in emergence and selec-
tion of these ESBL phenotypes in the
community. We could not establish a
relationship between the different
strains isolated in hospitalized and
ambulatory patients. Because of the
implications for treating such infec-
tions, particularly in developing coun-
tries, the spread of ESBL-producing
Enterobacteriaceae merits close sur-
veillance in the Central African
Republic.
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Novel Recombinant
Sapovirus, Japan 
To the Editor: Sapovirus is the
distinct genus within the family
Caliciviridae; these viruses cause spo-
radic cases and outbreaks of gastroen-
teritis in humans worldwide (1). The
sapovirus genome contains 2 open
reading frames (ORFs). ORF1
encodes nonstructural and capsid pro-
teins while ORF2 encodes a small pro-
tein (2). Sapovirus has a typical “Star
of David” configuration by electron
microscopic examination. The proto-
type sapovirus is the Sapporo virus
(Hu/SaV/Sapporo virus/1977/ JP),
which was originally discovered from
an outbreak in a home for infants in
Sapporo, Japan, in 1977 (3). Sapovirus
is divided into 5 genogroups, among
which only genogroups I, II, IV, and V
are known to infect humans (4).
A fecal specimen was collected
from a 1-year-old boy with acute gas-
troenteritis in Osaka, Japan, in March
2005. The viral genome was extracted
by using a QIAamp kit (Quigen,
Hilden, Germany). By using multi-
plex reverse transcription–polymerase
chain reaction (RT-PCR), 2 groups of
diarrheal viruses were identified. The
first group included astrovirus,
norovirus, and sapovirus; the second
group included rotavirus and aden-
ovirus (5). Sapovirus polymerase
region was also amplified to identify
recombinant sapovirus by using
primers P290 and P289 (6). To elimi-
nate the possibility of co-infection of
2 different sapovirus genotypes, to
localize the potential recombination
site, and to understand a possible
recombination mechanism of recom-
binant sapovirus, flanking polymerase
and capsid regions, with their junction
of HU/5862/Osaka/JP, were amplified
with primers P290 and SLV5749 to
produce a 1,162-bp product (5,6).
Products were directly sequenced, and
capsid- and polymerase-based phylo-
genetic trees showed recombinant
sapovirus.
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The fecal specimen was positive
for sapovirus. HU/5862/Osaka/JP
clustered into the genogroup I geno-
type 8 (GI/8 the 8/DCC/Tokyo/JP/44
cluster) (Figure) by using the recent
sapovirus capsid region classification
(7). HU/5862/Osaka/JP with GI/8
capsid was classified into GI/1 (the
Sapporo/82 cluster) when poly-
merase-based grouping was per-
formed. When the sequence of
HU/5862/Osaka/JP was compared
with that of Sapporo/82 by using
SimPlot Version 1.3 (available from
http://sray.med.som.jhmi.edu/SCRoft
ware/simplot), the recombination site
was identified at the polymerase-cap-
sid junction. Before this junction,
sequences of HU/5862/Osaka/JP and
Sapporo/82 were highly homologous.
However, homology between them
was notably different after the junc-
tion, with a sudden drop in the identi-
ty for HU/5862/Osaka/JP. By using
ClustalX, HU/5862/Osaka/JPshared a
96% identity in polymerase sequence
and an 85% identity in capsid
sequence with Sapporo/82. In con-
trast, homology was 99% in the cap-
sid region between HU/5862/Osaka/
JP and 8/DCC/Tokyo/JP/44. Since a
polymerase sequence of 8/DCC/
Tokyo/JP/44 was not available in
GenBank because of the unsuccessful
amplification, homology in the poly-
merase region between HU/5862/
Osaka/JP and 8/DCC/Tokyo/JP/44
was unknown. 
Altogether, the findings under-
scored that HU/5862/Osaka/JP repre-
sented a novel, naturally occurring,
recombinant sapovirus with GI/8 cap-
sid and GI/1 polymerase. To deter-
mine whether the child was infected
with this novel recombinant sapovirus
or whether the novel recombinant
sapovirus resulted from co-infection
with 2 different viruses, Svppo
(Sapporo/82-specific primer), Svdcc
(8/DCC/Tokyo/JP/44-specific
primer), and SLV5749 were used to
amplify the capsid region (5).
However, no amplicon was found.
These negative results indicate no co-
infection in this child.
Even though many molecular epi-
demiologic studies on sapovirus
infection have been performed world-
wide, reports documenting recombi-
nation in sapovirus are still limited.
The first recombinant sapovirus iden-
tified was the Thai isolate Mc10 or the
Japanese isolate C12 (8); the Japanese
isolate Ehime1107 and the SW278
isolate from Sweden were identified
later (9). Recombination occurred
only in sapovirus genogroup II, which
is more capable of recombination than
other genogroups (8,9). In this study,
we identified HU/5862/Osaka/JP with
a novel recombination between 2 dis-
tinct genotypes within genogroup I.
This is the first report of acute gas-
troenteritis caused by recombinant
sapovirus genogroup I. The findings
underscore that natural recombination
occurs not only in sapovirus
genogroup II but also in genogroup I.
In recent studies of sapovirus
recombination, evidence for the loca-
tion of the recombination event is
lacking because of the distant geo-
graphic relationship of parent and
progeny strains. HU/5862/Osaka/JP
shared the closest sequences of poly-
merase and capsid with Sapporo/82
and 8/DCC/Tokyo/JP/44, respective-
ly. Sapporo/82 was first isolated in
1982, and 8/DCC/Tokyo/JP/44 was
isolated in 2000, both in Japan.
Possibly, Sapporo/82 and
8/DCC/Tokyo/JP/44 were parental
strains of HU/5862/Osaka/JP, and the
event leading to the novel recombina-
tion might have occurred in Japan.
The capsid region was used for
genotype classification of sapovirus
(7). When capsid-based grouping was
performed, HU/5862/Osaka/JP dis-
tinctly belonged to genotype 8. When
polymerase-based grouping was
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Figure. Changing genotypes of sapovirus on the basis of phylogenetic trees. Trees were
constructed from partial amino acid sequences of capsid and polymerase of
HU/5862/Osaka/JP highlighted in italics. Phylogenetic tree with 1,000 bootstrap resam-
ples of the nucleotide alignment datasets was generated by using the neighbor-joining
method with ClustalX. The genetic distance was calculated by using Kimura 2-parameter
method (PHYLIP). The scale indicates amino acid substitutions per position. The numbers
in branches indicate bootstrap values. Porcine enteric calicivirus was used as an outgroup
strain for phylogenetic analysis. The nucleotide sequence data of sapovirus strain
HU/5862/Osaka/JP has been submitted to GenBank and has been assigned accession
no. DQ318530. Reference sapovirus strains and accession nos. used in this study were
as follows: PEC (AF182760), London/92 (U95645), Arg39 (AY289803), Parkville/94
(U73124), Manchester/93 (X86560), Sapporo/82 (U65427), Hou7-1181/90 (AF435814),
and 8/DCC/Tokyo/Japan/44 (AB236377).LETTERS
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performed, HU/5862/Osaka/JP dis-
tinctly belonged to genotype 1.
Therefore, sapovirus classification
based on capsid sequence is question-
able. We suggest that sapovirus classi-
fication should rely not only on capsid
sequence but also on polymerase
sequence.
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Postmortem
Confirmation of
Human Rabies
Source 
To the Editor: Rabies is a fatal
encephalitis caused by a neurotropic
RNA virus of the family
Rhabdoviridae, genus Lyssavirus. The
predominant rabies virus reservoir
hosts are bats and carnivores. Among
these, rabid dogs represent a substan-
tial public health problem, particular-
ly in developing countries (1).
Laboratory diagnosis of rabies is
essential to guide control programs,
epidemiologic surveys, and prophy-
lactic measures (2). Among the labo-
ratory tests recommended by the
World Health Organization (WHO),
the fluorescent antibody test (FAT) is
the accepted standard for rabies diag-
nosis (1). Although rabies virus anti-
gens can be detected in decomposed
samples, FAT is less effective when
such samples are tested. In those
cases, polymerase chain reaction
(PCR) can provide better results (3).
Since the degree of decomposition at
which FAT starts to become ineffec-
tive is unknown (4), when smears
from decomposed samples are made
for FAT, a suspension of the same
brain tissues should be made in the
appropriate diluents for the mouse
inoculation test (MIT), cell culture, or
reverse transcription–polymerase
chain reaction (RT-PCR) (2). How-
ever, if all test results are negative,
rabies cannot be ruled out because of
the condition of the sample.
On February 28, in the city of
Carbonita, Minas Gerais State, in
southeastern Brazil, a 62-year-old
man was bitten by a bat on the right
ankle. Approximately 50 days later,
his leg began to feel numb, and he
experienced a continuous headache,
pain at the site of the bite, convul-
sions, frequent urge to clear his throat,
hiccups, nausea, difficulty in swal-
lowing, dry lips, slightly elevated
body temperature (37°C–37.5°C),
paralysis of superior and inferior left
limbs, shaking, and hallucinations. On
May 4, 16 days after clinical manifes-
tations began, the patient died; the
cause of death was registered as a
cerebral vascular accident. One month
later, the body was exhumed to obtain
a sample from the central nervous sys-
tem (CNS), which was sent to
Instituto Pasteur, São Paulo, regis-
tered as sample 5341 M/04 and tested
by FAT, MIT, and RT-PCR.
In total, 8 smears were prepared
from the sample to be analyzed by
FAT according to the method of Dean
et al. (5) with fluorescein isothio-
cyanate–labeled polyclonal antinucle-
ocapsid antibodies. MIT was carried
out as described by Koprowski (6)
with 7 mice. For RT-PCR, RNA was
extracted from the CNS sample with
TRIzol, according to the manufactur-
er’s instructions (Invitrogen,
Rockville, MD, USA). RT-PCR was
carried out with modifications as
described by Orciari et al. (7), with
primers 504 (sense) and 304 (anti-
sense), aiming at the amplification of
a 249-bp fragment of rabies virus
nucleoprotein (N) gene, by using
Superscript II (Invitrogen) and Taq
DNA-polymerase (Invitrogen).
Fluorescent inclusions were
observed in 6 of the 8 slides prepared
for the FAT. The RT-PCR of the RNA